McCrea, Zita and Arnanthigo, Yonsuang and Cryan, Sally-Ann and O'Dea, Shirley
(2018)
A Novel Methodology for Bio-electrospraying Mesenchymal Stem
Cells that Maintains Differentiation, Immunomodulatory
and Pro-reparative Functions.
Journal of Medical and Biological Engineering, 38.
pp. 497-513.
ISSN 1609-0985
Abstract
Mesenchymal stem cells (MSCs) are an important cell source for tissue engineering (TE) and cell therapies for several reasons including ease of isolation from
multiple tissues, uncomplicated ex vivo culture, ability to
self-renew and differentiate into numerous cell types,
MSC/immune cell interactions and pro-reparative properties. Current MSC therapies involve administration via
intravenous (I.V.) injection. However, this can result in
MSC entrapment and failure to target injured site. In TE,
artificial 3D constructs are being investigated as strategies
for direct delivery of MSCs to a target area. However, these
constructs have numerous limitations including lack of cell
infiltration, poor cell functionality and limited diffusion of
nutrients and oxygen through the scaffolds. We are investigating the jetting methodology bio-electrospraying (BES)
as an alternative strategy for MSCs delivery in vivo that
may overcome obstacles associated with I.V. injections and
scaffold transplantation. For BES in vivo, low voltages,
stable jetting and a single needle configuration are highly
desirable. A commercially available electrospray apparatus
Spraybase was used to electrospray mouse bone marrowderived MSCs (mBMSCs) at low voltages (* 3–6 kV)
in vitro. Stable jetting conditions with a single needle at
these low voltages were established by employing a ringshape electrode for potential difference, specific culture
medium and the use of high mBMSCs numbers to overcome viscosity difficulties. The viability and functionality
of the mBMSCs following BES was determined by analysing expression of specific surface markers, multilineage
differentiation, suppression of T- cell activation and proreparative capabilities. We show that mBMSCs post-BES
functioned similarly to non-bio-electrospray (non-BES)
control mBMSCs for all parameters examined. This
methodology may subsequently enable targeted delivery of
MSCs to an injury site in vivo and potentially avoid the
complications associated with MSCs entrapment and the
limitations associated with artificial scaffolds.
Item Type: |
Article
|
Keywords: |
Bio-electrospraying; Mesenchymal stromal;
stem cells; Cell delivery; Tissue engineering; Cell
therapies; Bone marrow stem cells; |
Academic Unit: |
Faculty of Science and Engineering > Biology |
Item ID: |
13200 |
Identification Number: |
https://doi.org/10.1007/s40846-017-0331-4 |
Depositing User: |
Dr. Shirley O'Dea
|
Date Deposited: |
28 Aug 2020 13:53 |
Journal or Publication Title: |
Journal of Medical and Biological Engineering |
Publisher: |
Springer |
Refereed: |
Yes |
URI: |
|
Use Licence: |
This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available
here |
Repository Staff Only(login required)
|
Item control page |
Downloads per month over past year
Origin of downloads